MAP2K7 and autosomal dominant polycystic kidney disease: As abnormal renal epithelial cell proliferation in ADPKD is associated with cAMP-induced activation of the B-Raf/MEK/ERK pathway [24], we attempted to examine whether the treatment with PAC+ATRA affects the MEK/ERK pathway and consequently controls ADPKD epithelial cell growth.